The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

MODY 2 (GCK-MODY)

Glucokinase mutation causing mild stable hyperglycemia

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is MODY 2 (GCK-MODY)?

Glucokinase serves as the pancreatic beta cell glucose sensor, regulating insulin secretion in response to plasma glucose.

Heterozygous loss-of-function GCK mutations raise the glucose set-point so insulin is secreted at higher glucose levels but otherwise normally.

GCK-MODY accounts for 10–60 percent of MODY cases depending on population.

Inheritance is autosomal dominant with very high penetrance — fasting hyperglycemia is detectable from birth.

It is critically important to distinguish from type 1 or type 2 diabetes because pharmacotherapy is generally unnecessary and ineffective.

Symptoms

Stable mild fasting hyperglycemia (typically 5.5–8 mmol/L)
HbA1c usually 5.6–7.6 percent throughout life
Asymptomatic in most patients — discovered on routine screening or during pregnancy
Limited rise in postprandial glucose (typically less than 3 mmol/L increment)
Absence of microvascular or macrovascular complications even after decades
Normal lipid profile and normal fasting C-peptide

Risk Factors

Heterozygous mutation in the GCK gene (autosomal dominant inheritance)
Family history of mild lifelong hyperglycemia or 'gestational diabetes that never resolved'
Multiple family members across generations diagnosed with diabetes at very young age but not requiring insulin
Negative islet autoantibodies (distinguishes from type 1)
Lean body habitus without metabolic syndrome (helps distinguish from type 2)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Childhood or adolescent diagnosis of mild diabetes without typical type 1 or type 2 features
  • Persistent mild hyperglycemia detected during pregnancy with strong family history
  • Multiple affected family members with diabetes diagnosed under age 25
  • Diabetes that fails to progress despite years without treatment
  • Negative autoantibodies and preserved C-peptide in a young patient

Treatment Methods

01
Genetic confirmation by GCK sequencing — definitive and changes management
02
No pharmacotherapy required outside of pregnancy in the great majority of patients
03
Healthy lifestyle counseling but strict glucose control offers no proven benefit
04
In pregnancy: only treat if fetus does not carry the mutation (suggested by ultrasound growth above 75th percentile by 26–28 weeks)
05
If treatment indicated in pregnancy, insulin is preferred
06
Reassurance about extremely low risk of microvascular complications
07
Cascade genetic testing of first-degree relatives

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.